Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Magnitude and factors associated with delayed initiation of breastfeeding among mothers who deliver in Mulago hospital, Uganda.

Kalisa R, Malande O, Nankunda J, Tumwine JK.

Afr Health Sci. 2015 Dec;15(4):1130-5. doi: 10.4314/ahs.v15i4.11.

2.

Resistance to reverse transcriptase inhibitors used in the treatment and prevention of HIV-1 infection.

Sluis-Cremer N, Wainberg MA, Schinazi RF.

Future Microbiol. 2015;10(11):1773-82. doi: 10.2217/fmb.15.106. Epub 2015 Oct 30. Review.

PMID:
26517190
3.

[Evaluation of antiretroviral therapy on mother to child transmission HIV in HIV-1 positive pregnant women: case of St. Camillus Medical Center in Ouagadougou, Burkina Faso].

Soubeiga ST, Compaore R, Djigma F, Zagre N, Assengone E, Traore L, Diarra B, Bisseye C, Ouermi D, Sagna T, Karou S, Pietra V, Simpore J.

Pan Afr Med J. 2015 Apr 23;20:399. doi: 10.11604/pamj.2015.20.399.5627. eCollection 2015. French. No abstract available.

4.

Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.

Olson SC, Ngo-Giang-Huong N, Beck I, Deng W, Britto P, Shapiro DE, Bumgarner RE, Mullins JI, Van Dyke RB, Jourdain G, Frenkel LM.

AIDS. 2015 Jul 31;29(12):1467-71. doi: 10.1097/QAD.0000000000000737.

5.

Factors Associated with the Development of Drug Resistance Mutations in HIV-1 Infected Children Failing Protease Inhibitor-Based Antiretroviral Therapy in South Africa.

Rossouw TM, Feucht UD, Melikian G, van Dyk G, Thomas W, du Plessis NM, Avenant T.

PLoS One. 2015 Jul 21;10(7):e0133452. doi: 10.1371/journal.pone.0133452. eCollection 2015.

6.

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.

Musoke P, Szubert AJ, Musiime V, Nathoo K, Nahirya-Ntege P, Mutasa K, Williams DE, Prendergast AJ, Spyer M, Walker AS, Gibb DM; ARROW Trial Team.

AIDS. 2015 Aug 24;29(13):1623-32. doi: 10.1097/QAD.0000000000000749.

7.

Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique.

Antunes F, Zindoga P, Gomes P, Augusto O, Mahumane I, Veloso L, Valadas E, Camacho R.

PLoS One. 2015 Jul 10;10(7):e0131994. doi: 10.1371/journal.pone.0131994. eCollection 2015.

8.

Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy.

Lange CM, Hué S, Violari A, Cotton M, Gibb D, Babiker A, Otwombe K, Panchia R, Dobbels E, Jean-Philippe P, McIntyre JA, Pillay D, Gupta RK.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):138-44. doi: 10.1097/QAI.0000000000000568.

9.

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland.

Duong T, Judd A, Collins IJ, Doerholt K, Lyall H, Foster C, Butler K, Tookey P, Shingadia D, Menson E, Dunn DT, Gibb DM; Collaborative HIV Paediatric Study Steering Committee.

AIDS. 2014 Oct 23;28(16):2395-405.

10.

Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.

Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, van de Wijgert J, Asiimwe A, Reiss P, Geelen SP.

PLoS One. 2014 Nov 3;9(11):e111948. doi: 10.1371/journal.pone.0111948. eCollection 2014.

11.

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

Singh K, Flores JA, Kirby KA, Neogi U, Sonnerborg A, Hachiya A, Das K, Arnold E, McArthur C, Parniak M, Sarafianos SG.

Viruses. 2014 Sep 24;6(9):3535-62. doi: 10.3390/v6093535. Review.

12.

Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.

Ndondoki C, Dicko F, Ahuatchi Coffie P, Kassi Eboua T, Ekouevi DK, Kouadio K, Edmond Aka A, Malateste K, Dabis F, Amani-Bosse C, Toure P, Leroy V; Paediatric IeDEA West African Working Group.

J Int AIDS Soc. 2014 Jun 2;17:18737. doi: 10.7448/IAS.17.1.18737. eCollection 2014.

13.

HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial.

Liegler T, Abdel-Mohsen M, Bentley LG, Atchison R, Schmidt T, Javier J, Mehrotra M, Eden C, Glidden DV, McMahan V, Anderson PL, Li P, Wong JK, Buchbinder S, Guanira JV, Grant RM; iPrEx Study Team.

J Infect Dis. 2014 Oct 15;210(8):1217-27. doi: 10.1093/infdis/jiu233. Epub 2014 Apr 16.

14.

HIV-1 drug mutations in children from northern Tanzania.

Shao ER, Kifaro EG, Chilumba IB, Nyombi BM, Moyo S, Gaseitsiwe S, Musonda R, Johannessen A, Kibiki G, Essex M.

J Antimicrob Chemother. 2014 Jul;69(7):1928-32. doi: 10.1093/jac/dku087. Epub 2014 Apr 11.

15.

Patterns of transmitted HIV drug resistance in Europe vary by risk group.

Frentz D, van de Vijver D, Abecasis A, Albert J, Hamouda O, Jørgensen L, Kücherer C, Struck D, Schmit JC, Vercauteren J, Asjö B, Balotta C, Bergin C, Beshkov D, Camacho R, Clotet B, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis L, Linka KL, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher C, Wensing A; SPREAD Programme.

PLoS One. 2014 Apr 10;9(4):e94495. doi: 10.1371/journal.pone.0094495. eCollection 2014.

16.

Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women.

Huntington S, Thorne C, Anderson J, Newell ML, Taylor GP, Pillay D, Hill T, Tookey P, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study; National Study of HIV in Pregnancy and Childhood (NSHPC).

BMC Infect Dis. 2014 Mar 4;14:127. doi: 10.1186/1471-2334-14-127.

17.

HIV Drug Resistance: Problems and Perspectives.

Pennings PS.

Infect Dis Rep. 2013 Jun 6;5(Suppl 1):e5. doi: 10.4081/idr.2013.s1.e5. eCollection 2013 Jun 6. Review.

18.

The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.

Kébé K, Bélec L, Diop Ndiaye H, Bousso Gueye S, Abdallah Malick Diouara A, Ngom S, Rama Diagne Gueye N, Mbaye N, Signaté Sy H, Mboup S, Touré Kane C.

J Int AIDS Soc. 2014 Jan 16;17:18526. doi: 10.7448/IAS.17.1.18526. eCollection 2014.

19.

Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic.

Sebunya R, Musiime V, Kitaka SB, Ndeezi G.

AIDS Res Ther. 2013 Nov 11;10(1):25. doi: 10.1186/1742-6405-10-25.

20.

Short communication: Transmitted HIV drug resistance in antiretroviral-naive pregnant women in north central Nigeria.

Imade GE, Sagay AS, Chaplin B, Chebu P, Musa J, Okpokwu J, Hamel DJ, Pam IC, Agbaji O, Samuels J, Meloni S, Sankale JL, Okonkwo P, Kanki P.

AIDS Res Hum Retroviruses. 2014 Feb;30(2):127-33. doi: 10.1089/AID.2013.0074. Epub 2013 Nov 22.

Items per page

Supplemental Content

Write to the Help Desk